Adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B: a review of the major clinical studies.
Dusheiko
Geoffrey
G
Centre for Hepatology, School of Medicine, Royal Free and University College, Royal Free Campus, London NW3 2PF, UK. g.dusheiko@rfc.ucl.ac.uk
D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D006513:Hepatitis B e Antigens / Q000032:analysis*; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000276:immunology*; D006801:Humans; D063065:Organophosphonates; D016032:Randomized Controlled Trials as Topic
D000998:Antiviral Agents; D006513:Hepatitis B e Antigens; D063065:Organophosphonates; D000225:Adenine; C106812:adefovir dipivoxil